Loading organizations...
Bloom Diagnostics: Medtech company developing smart diagnostic devices and software for at-home & retail blood tests, instant health insights.
Based in Zurich, Switzerland, Bloom Diagnostics develops smart diagnostic hardware and cloud-based software that enable users to perform rapid blood tests in home or retail settings. The company's proprietary Bloom Lab reader processes samples and delivers personalized health insights and result explanations through a connected application within ten minutes. Operating under both business-to-business and direct-to-consumer models, the platform serves individual users as well as retail pharmacies seeking to offer point-of-care health services. The diagnostic system is designed to identify and track various medical conditions and biomarkers, including ferritin levels, thyroid function, AMH, and COVID-19 antibodies. The medical technology firm operates with a workforce of approximately 70 employees and has secured $10 million in Series B venture capital funding to scale its operations. Bloom Diagnostics was founded in 2018 by Dr. Angelica Kohlmann and Thomas Kupper.
Bloom Diagnostics has raised $11.9M across 1 funding round.
Bloom Diagnostics has raised $11.9M in total across 1 funding round.
Bloom Diagnostics has raised $11.9M in total across 1 funding round.
Bloom Diagnostics's investors include Thomas Pfisterer.
Bloom Diagnostics has raised $11.9M across 1 funding round. Most recently, it raised $11.9M Series B in August 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 19, 2020 | $11.9M Series B | Thomas Pfisterer |